Nutriband Inc. (NASDAQ: NTRB) has announced the key dates for its upcoming 25% preferred stock dividend, a move that underscores the company’s commitment to rewarding its shareholders while advancing its pharmaceutical innovations. Shareholders of record as of July 25, 2025, will be entitled to receive one preferred share for every four common shares held, with the dividend payable on August 5, 2025. This strategic financial decision not only benefits shareholders but also ties directly into the company’s developmental milestones, particularly the FDA approval of its AVERSA Fentanyl product.

The preferred shares issued as part of this dividend will carry the option to convert into common shares upon the FDA’s approval of Nutriband’s AVERSA Fentanyl product. This unique feature aligns shareholder interests with the company’s regulatory and developmental achievements, offering a tangible link between investment returns and corporate progress. Furthermore, preferred shares that remain unconverted will be eligible for annual cash dividends, distributed at the discretion of the board from company profits, providing an additional layer of value to investors.

Nutriband’s focus on developing transdermal pharmaceutical products, especially its lead product incorporating the AVERSA abuse-deterrent technology, positions the company at the forefront of addressing critical issues in drug abuse and misuse. The AVERSA technology is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential, marking a significant advancement in pharmaceutical safety and efficacy.

This announcement is pivotal for investors and the pharmaceutical industry alike, as it not only highlights Nutriband’s financial strategies to enhance shareholder value but also underscores the company’s progress in bringing innovative, abuse-deterrent pharmaceutical products to market. The linkage between the preferred stock dividend and the FDA approval of the AVERSA Fentanyl product serves as a testament to Nutriband’s commitment to achieving significant regulatory and commercial milestones.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Nutriband Inc. Announces Key Dates for 25% Preferred Stock Dividend.